Arbutus Biopharma Corporation

ABUS · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$22,408$37,412$37,076$36,330
Short-Term Investments$71,294$60,676$75,631$86,293
Receivables$905$1,025$1,182$2,409
Inventory$0$0$0$0
Other Curr. Assets$2,835$4,006$2,919$2,284
Total Curr. Assets$97,442$103,119$116,808$127,316
Property Plant & Equip (Net)$137$148$168$4,357
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$131$0$34$34
Total NC Assets$268$148$202$4,391
Other Assets$0$0$0$0
Total Assets$97,710$103,267$117,010$131,707
Liabilities
Payables$1,011$1,321$2,240$2,316
Short-Term Debt$531$514$563$483
Tax Payable$0$0$0$0
Deferred Revenue$0$0$6,759$7,571
Other Curr. Liab.$3,642$3,187$9,869$5,248
Total Curr. Liab.$5,184$5,022$19,431$15,618
LT Debt$391$575$626$806
Deferred Rev, NC$0$0$2,863$2,863
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$14,736$14,694$14,933$15,054
Total NC Liab.$15,127$15,269$18,422$18,723
Other Liabilities$0$0$0$0
Cap. Leases$922$1,089$1,189$1,289
Total Liabilities$20,311$20,291$37,853$34,341
Equity
Pref Stock$0$0$0$0
Common Stock$1,418,560$1,417,110$1,416,332$1,410,025
Retained Earnings-$1,376,317-$1,368,575-$1,371,098-$1,346,572
AOCI-$48,129-$48,187-$48,166-$48,135
Other Equity$83,285$82,628$82,089$82,048
Total Equity$77,399$82,976$79,157$97,366
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$97,710$103,267$117,010$131,707
Net Debt-$21,486-$36,323-$35,887-$35,041